兆科药业（合肥）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
17
NMPA:17
Drug Approvals
Adapalene and Clindamycin Hydrochloride Gel
- Product Name
- 阿达帕林克林霉素凝胶
- Approval Number
- 国药准字H20240007
- Approval Date
- Feb 20, 2024
NMPA
Nadroparin Calcium Injection
- Product Name
- 那屈肝素钙注射液
- Approval Number
- 国药准字H20223356
- Approval Date
- May 31, 2022
NMPA
Nadroparin Calcium Injection
- Product Name
- 那屈肝素钙注射液
- Approval Number
- 国药准字H20223355
- Approval Date
- May 31, 2022
NMPA
Low Molecular Weight Heparin Calcium
- Product Name
- 低分子量肝素钙
- Approval Number
- 国药准字H10980164
- Approval Date
- Apr 1, 2021
NMPA
Fondaparinux sodium Injection
- Product Name
- 磺达肝癸钠注射液
- Approval Number
- 国药准字H20213107
- Approval Date
- Feb 2, 2021
NMPA
Nadroparin Calcium for Injection
- Product Name
- 立迈青
- Approval Number
- 国药准字H10980166
- Approval Date
- Sep 4, 2020
NMPA
Nadroparin Calcium for Injection
- Product Name
- 立迈青
- Approval Number
- 国药准字H10980165
- Approval Date
- Jul 22, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found